GlobeNewswire 6/4 Stipple Bio Enters Multi-Target License Agreement with Lonza to Advance Precision Oncology ADC Thera...
GlobeNewswire 5/27 AsymBio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generati...
GlobeNewswire 5/11 CPTx appoints Edward Rebar as Chief Scientific Officer
GlobeNewswire 5/6 Vaxcyte Reports First Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire 5/4 Ardena Strengthens Executive Team to Drive its Next Phase of Growth
GlobeNewswire 3/9 MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
TMX Newsfile 3/5 Octane Medical Group Signs Agreement to Acquire Lonza's Personalized Medicine Business
GlobeNewswire 2/24 Vaxcyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
GlobeNewswire 2/12 CRB Appoints John R. Lupa, Jr. as Vice President, National Construction
GlobeNewswire 12/11/2025 Eukarÿs Wins 2025 BioTools Innovator Grand Prize and Joins BARDA’s Elite VANGUARD Program
GlobeNewswire 12/8/2025 Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025
GlobeNewswire 11/12/2025 MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress
GlobeNewswire 11/10/2025 Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial ...
GlobeNewswire 11/4/2025 Vaxcyte Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Da...
GlobeNewswire 11/3/2025 Galapagos to Present New Data from Cell Therapy Program at ASH 2025
GlobeNewswire 9/8/2025 ElevateBio Appoints Larry Lockwood, Ph.D., as Chief Commercial Officer
GlobeNewswire 8/14/2025 MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities
GlobeNewswire 8/7/2025 Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire 8/6/2025 Vaxcyte Reports Second Quarter 2025 Financial Results and Provides Business Update, Highlighting Key...
GlobeNewswire 8/6/2025 Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to...
GlobeNewswire 7/23/2025 Galapagos Reports Half-Year 2025 Financial Results and Provides Second Quarter Business Update
GlobeNewswire 6/18/2025 Galapagos Presented New Data at ICML 2025 From Cohort 3 of ATALANTA-1 in Relapsed/Refractory Indolen...
GlobeNewswire 6/12/2025 Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Dec...
GlobeNewswire 5/28/2025 ABLi Therapeutics Strengthens Leadership Team and Board of Directors
GlobeNewswire 5/15/2025 Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Al...